These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas. Yang W; Barth RF; Wu G; Bandyopadhyaya AK; Thirumamagal BT; Tjarks W; Binns PJ; Riley K; Patel H; Coderre JA; Ciesielski MJ; Fenstermaker RA Appl Radiat Isot; 2004 Nov; 61(5):981-5. PubMed ID: 15308179 [TBL] [Abstract][Full Text] [Related]
10. Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Pan XQ; Wang H; Shukla S; Sekido M; Adams DM; Tjarks W; Barth RF; Lee RJ Bioconjug Chem; 2002; 13(3):435-42. PubMed ID: 12009931 [TBL] [Abstract][Full Text] [Related]
11. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy. Stephenson SM; Yang W; Stevens PJ; Tjarks W; Barth RF; Lee RJ Anticancer Res; 2003; 23(4):3341-5. PubMed ID: 12926073 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors. Yang W; Barth RF; Adams DM; Soloway AH Cancer Res; 1997 Oct; 57(19):4333-9. PubMed ID: 9331095 [TBL] [Abstract][Full Text] [Related]
13. Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes. Pan XQ; Wang H; Lee RJ Anticancer Res; 2002; 22(3):1629-33. PubMed ID: 12168846 [TBL] [Abstract][Full Text] [Related]
15. Targeted drug delivery for boron neutron capture therapy. Mehta SC; Lu DR Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724 [TBL] [Abstract][Full Text] [Related]
16. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor. Carlsson J; Gedda L; Grönvik C; Hartman T; Lindström A; Lindström P; Lundqvist H; Lövqvist A; Malmqvist J; Olsson P Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):105-15. PubMed ID: 7521866 [TBL] [Abstract][Full Text] [Related]
17. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Yang W; Barth RF; Adams DM; Ciesielski MJ; Fenstermaker RA; Shukla S; Tjarks W; Caligiuri MA Cancer Res; 2002 Nov; 62(22):6552-8. PubMed ID: 12438250 [TBL] [Abstract][Full Text] [Related]
18. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Gedda L; Olsson P; Pontén J; Carlsson J Bioconjug Chem; 1996; 7(5):584-91. PubMed ID: 8889021 [TBL] [Abstract][Full Text] [Related]
19. Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. Callahan DE; Forte TM; Afzal SM; Deen DF; Kahl SB; Bjornstad KA; Bauer WF; Blakely EA Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):761-71. PubMed ID: 10524433 [TBL] [Abstract][Full Text] [Related]
20. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]